Synthesis and Monoamine Transporter Binding Properties of 2,3-Diaryltropanes

Synthetic procedures were developed for the synthesis of 2β,3β- and 2α,3α-diaryltropanes. These compounds are analogues of the 3-aryltropane-2β-carboxylic acid methyl ester class of monoamine uptake inhibitors, where the 2β-carbomethoxy group has been replaced by an aryl group. The compounds were ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2005-11, Vol.48 (23), p.7437-7444
Hauptverfasser: Kotturi, Sharadsrikar V, Jiang, Songchun, Chang, An-Chih, Abraham, Philip, Navarro, Hernán A, Kuhar, Michael J, Carroll, F. Ivy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7444
container_issue 23
container_start_page 7437
container_title Journal of medicinal chemistry
container_volume 48
creator Kotturi, Sharadsrikar V
Jiang, Songchun
Chang, An-Chih
Abraham, Philip
Navarro, Hernán A
Kuhar, Michael J
Carroll, F. Ivy
description Synthetic procedures were developed for the synthesis of 2β,3β- and 2α,3α-diaryltropanes. These compounds are analogues of the 3-aryltropane-2β-carboxylic acid methyl ester class of monoamine uptake inhibitors, where the 2β-carbomethoxy group has been replaced by an aryl group. The compounds were evaluated for inhibition of radioligand binding at the dopamine, norepinephrine, and serotonin transporters (DAT, NET, and 5-HTT, respectively). The results showed that the replacement of the 2β-carbomethoxy group in the 3-aryltropane class with a 2β-aryl group led to compounds possessing very similar monoamine transporter binding properties. However, the 2β,3β-diaryltropanes tended to be more potent at the DAT and more selective for the DAT relative to the NET and 5-HTT. One of the most interesting compounds was 3β-(4-methylphenyl)-2β-(4-methylphenyl)tropane (3d), which showed an IC50 of 1.23 nM at the DAT with 289- and 185-fold selectivity for the DAT relative to the NET and 5-HTT. The 2α,3α-diaryltropanes were much less potent at all three transporters than 2β,3β-diaryltropanes.
doi_str_mv 10.1021/jm0582423
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68795205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68795205</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-92b3a1377729d8b5363edc855fe7b88b452bc3780f82f2c07612687016859cc43</originalsourceid><addsrcrecordid>eNpt0EFv0zAYBmBrAm1lcOAPoFyYhESG_TmOneM2YEMromLdZRfLcZzNJbE7f6nE_j2eWq0XTpY-P3r16iXkPaOnjAL7shqpUFABPyAzJoCWlaLVKzKjFKCEGvgReYO4opRyBvyQHLEaZKMon5H5zVOYHhx6LEzoip8xRDP64IplMgHXMU0uFec-dD7cF4sU1y5N3mER-wI-8_KrN-lpmPLdBIdvyeveDOje7d5jcvv92_Liqpz_uvxxcTYvDVdsKhtouWFcSglNp1rBa-46q4TonWyVaisBreVS0V5BD5bKmkGtJGW1Eo21FT8mJ9vcdYqPG4eTHj1aNwy5RNygzrjJM4gMP22hTRExuV6vkx9zZc2ofp5Ov0yX7Ydd6KYdXbeXu60y-LgDBq0Z-jyQ9bh3EqQC-ezKrfM4ub8v_yb90bXkUujl4kYv767P5w381ot9rrGoV3GTQt7uPwX_AVj0j0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68795205</pqid></control><display><type>article</type><title>Synthesis and Monoamine Transporter Binding Properties of 2,3-Diaryltropanes</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Kotturi, Sharadsrikar V ; Jiang, Songchun ; Chang, An-Chih ; Abraham, Philip ; Navarro, Hernán A ; Kuhar, Michael J ; Carroll, F. Ivy</creator><creatorcontrib>Kotturi, Sharadsrikar V ; Jiang, Songchun ; Chang, An-Chih ; Abraham, Philip ; Navarro, Hernán A ; Kuhar, Michael J ; Carroll, F. Ivy</creatorcontrib><description>Synthetic procedures were developed for the synthesis of 2β,3β- and 2α,3α-diaryltropanes. These compounds are analogues of the 3-aryltropane-2β-carboxylic acid methyl ester class of monoamine uptake inhibitors, where the 2β-carbomethoxy group has been replaced by an aryl group. The compounds were evaluated for inhibition of radioligand binding at the dopamine, norepinephrine, and serotonin transporters (DAT, NET, and 5-HTT, respectively). The results showed that the replacement of the 2β-carbomethoxy group in the 3-aryltropane class with a 2β-aryl group led to compounds possessing very similar monoamine transporter binding properties. However, the 2β,3β-diaryltropanes tended to be more potent at the DAT and more selective for the DAT relative to the NET and 5-HTT. One of the most interesting compounds was 3β-(4-methylphenyl)-2β-(4-methylphenyl)tropane (3d), which showed an IC50 of 1.23 nM at the DAT with 289- and 185-fold selectivity for the DAT relative to the NET and 5-HTT. The 2α,3α-diaryltropanes were much less potent at all three transporters than 2β,3β-diaryltropanes.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm0582423</identifier><identifier>PMID: 16279803</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Binding, Competitive ; Biological and medical sciences ; Catecholaminergic system ; Dopamine Plasma Membrane Transport Proteins - metabolism ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Norepinephrine Plasma Membrane Transport Proteins - metabolism ; Pharmacology. Drug treatments ; Radioligand Assay ; Rats ; Serotonin Plasma Membrane Transport Proteins - metabolism ; Stereoisomerism ; Structure-Activity Relationship ; Tropanes - chemical synthesis ; Tropanes - chemistry ; Tropanes - metabolism</subject><ispartof>Journal of medicinal chemistry, 2005-11, Vol.48 (23), p.7437-7444</ispartof><rights>Copyright © 2005 American Chemical Society</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-92b3a1377729d8b5363edc855fe7b88b452bc3780f82f2c07612687016859cc43</citedby><cites>FETCH-LOGICAL-a381t-92b3a1377729d8b5363edc855fe7b88b452bc3780f82f2c07612687016859cc43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm0582423$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm0582423$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2763,27074,27922,27923,56736,56786</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17278273$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16279803$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kotturi, Sharadsrikar V</creatorcontrib><creatorcontrib>Jiang, Songchun</creatorcontrib><creatorcontrib>Chang, An-Chih</creatorcontrib><creatorcontrib>Abraham, Philip</creatorcontrib><creatorcontrib>Navarro, Hernán A</creatorcontrib><creatorcontrib>Kuhar, Michael J</creatorcontrib><creatorcontrib>Carroll, F. Ivy</creatorcontrib><title>Synthesis and Monoamine Transporter Binding Properties of 2,3-Diaryltropanes</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Synthetic procedures were developed for the synthesis of 2β,3β- and 2α,3α-diaryltropanes. These compounds are analogues of the 3-aryltropane-2β-carboxylic acid methyl ester class of monoamine uptake inhibitors, where the 2β-carbomethoxy group has been replaced by an aryl group. The compounds were evaluated for inhibition of radioligand binding at the dopamine, norepinephrine, and serotonin transporters (DAT, NET, and 5-HTT, respectively). The results showed that the replacement of the 2β-carbomethoxy group in the 3-aryltropane class with a 2β-aryl group led to compounds possessing very similar monoamine transporter binding properties. However, the 2β,3β-diaryltropanes tended to be more potent at the DAT and more selective for the DAT relative to the NET and 5-HTT. One of the most interesting compounds was 3β-(4-methylphenyl)-2β-(4-methylphenyl)tropane (3d), which showed an IC50 of 1.23 nM at the DAT with 289- and 185-fold selectivity for the DAT relative to the NET and 5-HTT. The 2α,3α-diaryltropanes were much less potent at all three transporters than 2β,3β-diaryltropanes.</description><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Catecholaminergic system</subject><subject>Dopamine Plasma Membrane Transport Proteins - metabolism</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Norepinephrine Plasma Membrane Transport Proteins - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Serotonin Plasma Membrane Transport Proteins - metabolism</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Tropanes - chemical synthesis</subject><subject>Tropanes - chemistry</subject><subject>Tropanes - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0EFv0zAYBmBrAm1lcOAPoFyYhESG_TmOneM2YEMromLdZRfLcZzNJbE7f6nE_j2eWq0XTpY-P3r16iXkPaOnjAL7shqpUFABPyAzJoCWlaLVKzKjFKCEGvgReYO4opRyBvyQHLEaZKMon5H5zVOYHhx6LEzoip8xRDP64IplMgHXMU0uFec-dD7cF4sU1y5N3mER-wI-8_KrN-lpmPLdBIdvyeveDOje7d5jcvv92_Liqpz_uvxxcTYvDVdsKhtouWFcSglNp1rBa-46q4TonWyVaisBreVS0V5BD5bKmkGtJGW1Eo21FT8mJ9vcdYqPG4eTHj1aNwy5RNygzrjJM4gMP22hTRExuV6vkx9zZc2ofp5Ov0yX7Ydd6KYdXbeXu60y-LgDBq0Z-jyQ9bh3EqQC-ezKrfM4ub8v_yb90bXkUujl4kYv767P5w381ot9rrGoV3GTQt7uPwX_AVj0j0A</recordid><startdate>20051117</startdate><enddate>20051117</enddate><creator>Kotturi, Sharadsrikar V</creator><creator>Jiang, Songchun</creator><creator>Chang, An-Chih</creator><creator>Abraham, Philip</creator><creator>Navarro, Hernán A</creator><creator>Kuhar, Michael J</creator><creator>Carroll, F. Ivy</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051117</creationdate><title>Synthesis and Monoamine Transporter Binding Properties of 2,3-Diaryltropanes</title><author>Kotturi, Sharadsrikar V ; Jiang, Songchun ; Chang, An-Chih ; Abraham, Philip ; Navarro, Hernán A ; Kuhar, Michael J ; Carroll, F. Ivy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-92b3a1377729d8b5363edc855fe7b88b452bc3780f82f2c07612687016859cc43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Catecholaminergic system</topic><topic>Dopamine Plasma Membrane Transport Proteins - metabolism</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Norepinephrine Plasma Membrane Transport Proteins - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Serotonin Plasma Membrane Transport Proteins - metabolism</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Tropanes - chemical synthesis</topic><topic>Tropanes - chemistry</topic><topic>Tropanes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kotturi, Sharadsrikar V</creatorcontrib><creatorcontrib>Jiang, Songchun</creatorcontrib><creatorcontrib>Chang, An-Chih</creatorcontrib><creatorcontrib>Abraham, Philip</creatorcontrib><creatorcontrib>Navarro, Hernán A</creatorcontrib><creatorcontrib>Kuhar, Michael J</creatorcontrib><creatorcontrib>Carroll, F. Ivy</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kotturi, Sharadsrikar V</au><au>Jiang, Songchun</au><au>Chang, An-Chih</au><au>Abraham, Philip</au><au>Navarro, Hernán A</au><au>Kuhar, Michael J</au><au>Carroll, F. Ivy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Monoamine Transporter Binding Properties of 2,3-Diaryltropanes</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2005-11-17</date><risdate>2005</risdate><volume>48</volume><issue>23</issue><spage>7437</spage><epage>7444</epage><pages>7437-7444</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Synthetic procedures were developed for the synthesis of 2β,3β- and 2α,3α-diaryltropanes. These compounds are analogues of the 3-aryltropane-2β-carboxylic acid methyl ester class of monoamine uptake inhibitors, where the 2β-carbomethoxy group has been replaced by an aryl group. The compounds were evaluated for inhibition of radioligand binding at the dopamine, norepinephrine, and serotonin transporters (DAT, NET, and 5-HTT, respectively). The results showed that the replacement of the 2β-carbomethoxy group in the 3-aryltropane class with a 2β-aryl group led to compounds possessing very similar monoamine transporter binding properties. However, the 2β,3β-diaryltropanes tended to be more potent at the DAT and more selective for the DAT relative to the NET and 5-HTT. One of the most interesting compounds was 3β-(4-methylphenyl)-2β-(4-methylphenyl)tropane (3d), which showed an IC50 of 1.23 nM at the DAT with 289- and 185-fold selectivity for the DAT relative to the NET and 5-HTT. The 2α,3α-diaryltropanes were much less potent at all three transporters than 2β,3β-diaryltropanes.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>16279803</pmid><doi>10.1021/jm0582423</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2005-11, Vol.48 (23), p.7437-7444
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_68795205
source MEDLINE; American Chemical Society Journals
subjects Animals
Binding, Competitive
Biological and medical sciences
Catecholaminergic system
Dopamine Plasma Membrane Transport Proteins - metabolism
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Norepinephrine Plasma Membrane Transport Proteins - metabolism
Pharmacology. Drug treatments
Radioligand Assay
Rats
Serotonin Plasma Membrane Transport Proteins - metabolism
Stereoisomerism
Structure-Activity Relationship
Tropanes - chemical synthesis
Tropanes - chemistry
Tropanes - metabolism
title Synthesis and Monoamine Transporter Binding Properties of 2,3-Diaryltropanes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T10%3A50%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Monoamine%20Transporter%20Binding%20Properties%20of%202,3-Diaryltropanes&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Kotturi,%20Sharadsrikar%20V&rft.date=2005-11-17&rft.volume=48&rft.issue=23&rft.spage=7437&rft.epage=7444&rft.pages=7437-7444&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm0582423&rft_dat=%3Cproquest_cross%3E68795205%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68795205&rft_id=info:pmid/16279803&rfr_iscdi=true